524703.BO Stock Analysis
52
Avoid
Based on Eyestock quantitative analysis, 524703.BO`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Sandu Pharmaceuticals Ltd. engages in the manufacture and marketing of Ayurvedic medicines. The company is headquartered in Mumbai, Maharashtra. The firm's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The firm also offers products, such as an immunity kit and a power herbs range. The firm's products are sold through e-commerce marketplaces.